Inventor · disambiguated record
Jorg Vollmer
Also filed as: VOLLMER JOERG · VOLLMER JORG · VOLLMER JÖRG
16 granted patents·21 pending applications·550 citations·filing 2002–2022
95Inventor score
Top patents by PatentIndex Score
37 records- 0197US7566703B2Semi-soft C-class immunostimulatory oligonucleotidesCOLEY PHARM GROUP INC·Filed 2005·Granted Jul 28, 2009·69 cites·26 claims
- 0296US7615539B2Nucleic acid-lipophilic conjugatesCOLEY PHARM GROUP INC·Filed 2004·Granted Nov 10, 2009·76 cites·27 claims
- 0395US7956043B25′ CpG nucleic acids and methods of useCOLEY PHARM GROUP INC·Filed 2003·Granted Jun 7, 2011·82 cites·15 claims
- 0495US7795235B2Semi-soft c-class immunostimulatory oligonucleotidesCOLEY PHARM GMBH·Filed 2008·Granted Sep 14, 2010·35 cites·5 claims
- 0594US8304396B2Immunostimulatory nucleic acidsKRIEG ARTHUR M·Filed 2006·Granted Nov 6, 2012·38 cites·9 claims
- 0694US7271156B2Immunostimulatory nucleic acidsCOLEY PHARM GMBH·Filed 2002·Granted Sep 18, 2007·119 cites·33 claims
- 0790US8283328B2Immunostimulatory nucleic acidsKRIEG ARTHUR M·Filed 2003·Granted Oct 9, 2012·40 cites·11 claims
- 0885US8198251B2Combination motif immune stimulatory oligonucleotides with improved activityVOLLMER JORG·Filed 2008·Granted Jun 12, 2012·11 cites·1 claims
- 0985US7998492B2Methods and products related to treatment and prevention of hepatitis C virus infectionCOLEY PHARM GROUP INC·Filed 2003·Granted Aug 16, 2011·35 cites·1 claims
- 1084US8128944B2RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profilesJURK MARION·Filed 2008·Granted Mar 6, 2012·7 cites·6 claims
- 1182US8188254B2C-class oligonucleotide analogs with enhanced immunostimulatory potencyUHLMANN EUGEN·Filed 2004·Granted May 29, 2012·19 cites·50 claims
- 1280US8834900B2Combination motif immune stimulatory oligonucleotides with improved activityKRIEG ARTHUR M·Filed 2002·Granted Sep 16, 2014·13 cites·28 claims
- 1378US8354522B2Immunostimulatory oligoribonucleotidesCOLEY PHARM GMBH·Filed 2011·Granted Jan 15, 2013·3 cites·12 claims
- 1473US7662949B2Immunostimulatory oligoribonucleotidesCOLEY PHARM GMBH·Filed 2006·Granted Feb 16, 2010·1 cites·14 claims
- 1569US8466124B2RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profilesJURK MARION·Filed 2012·Granted Jun 18, 2013·1 cites·5 claims
- 1669US8227447B2RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profilesJURK MARION·Filed 2012·Granted Jul 24, 2012·1 cites·2 claims
- 1764US2010316659A1Immunostimulatory oligoribonucleotidesCOLEY PHARM GMBH·Filed 2009·Application pending·0 cites
- 1862US2010183639A1Nucleic acid-lipophilic conjugatesCOLEY PHARM GROUP INC·Filed 2009·Application pending·0 cites
- 1961US2009191188A1Immunostimulatory nucleic acidsUNIV IOWA RES FOUND·Filed 2009·Application pending·0 cites
- 2059US2022273741A1New virus particles for therapeutic purposesABALOS THERAPEUTICS GMBH·Filed 2022·Application pending·0 cites
- 2154US2005239733A1Sequence requirements for inhibitory oligonucleotidesCOLEY PHARM GROUP INC·Filed 2004·Application pending·0 cites
- 2254US2007066554A1Immunostimulatory nucleic acidsUNIV IOWA RES FOUND·Filed 2006·Application pending·0 cites
- 2353US2011135605A1Methods and products related to treatment and prevention of hepatitis c virus infectionCOLEY PHARM GROUP INC·Filed 2010·Application pending·0 cites
- 2453US2008045473A1Compositions and methods for oligonucleotide formulationsCOLEY PHARM GMBH·Filed 2007·Application pending·0 cites
- 2551US2008226649A1CPG-like nucleic acids and methods of use thereofCOLEY PHARM GMBH·Filed 2007·Application pending·0 cites
- 2650US2006188913A1Methods and products for enhancing immune responses using imidazoquinoline compoundsCOLEY PHARM GROUP INC·Filed 2006·Application pending·0 cites
- 2749US2010285041A1Class A Oligonucleotides with Immunostimulatory PotencyUHLMANN EUGEN·Filed 2008·Application pending·0 cites
- 2849US2018171338A1Compositions and methods for oligonucleotide formulationsADIU TIDE PHARMACEUTICALS GMBH·Filed 2018·Application pending·0 cites
- 2949US2006003962A1Methods and products related to treatment and prevention of hepatitis C virus infectionCOLEY PHARM GMBH·Filed 2005·Application pending·0 cites
- 3049US2011201672A1Semi-soft c-class immunostimulatory oligonucleotidesKRIEG ARTHUR M·Filed 2010·Application pending·0 cites
- 3148US2010144846A1Oligoribonucleotides and uses thereofCOLEY PHARM GMBH·Filed 2007·Application pending·0 cites
- 3248US2003181406A1CpG-like nucleic acids and methods of use thereofFiled 2002·Application pending·0 cites
- 3347US2003139364A1Methods and products for enhancing immune responses using imidazoquinoline compoundsUNIV IOWA RES FOUND·Filed 2002·Application pending·0 cites
- 3446US2010189772A1Compositions of TLR ligands and antiviralsCOLEY PHARM GROUP INC·Filed 2007·Application pending·0 cites
- 3544US2012219571A1Combination motif immune stimulatory oligonucleotides with improved activityVOLLMER JORG·Filed 2012·Application pending·0 cites
- 3643US2008009455A9Immunostimulatory oligonucleotidesCOLEY PHARM GROUP INC·Filed 2006·Application pending·0 cites
- 3742US2006019916A1Immunostimulatory nucleic acids for inducing IL-10 responsesCOLEY PHARM GROUP INC·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →